See the DrugPatentWatch profile for Abreva
Abreva is an over-the-counter topical treatment for cold sores [1]. Its active ingredient is docosanol 10% [1]. Docosanol works by helping to penetrate the skin and blocking the entry of the herpes simplex virus (HSV) into healthy cells, thereby preventing the spread of infection [1]. By shortening the healing time, Abreva aims to reduce the duration of cold sore symptoms [1].
How quickly does Abreva start working?
Abreva is designed to be applied at the first sign of a cold sore, such as tingling, itching, or burning [1]. When used as directed, it can start to heal cold sores by shortening healing time [1].
What are the ingredients in Abreva?
The active ingredient in Abreva is docosanol 10% [1]. Inactive ingredients include benzyl alcohol, emulsifying wax, light mineral oil, polyoxyl lauryl ether, polyoxyl stearyl ether, propylene glycol, purified water, and stearyl alcohol [1].
How does Abreva compare to other cold sore treatments?
Abreva's active ingredient, docosanol, works by a different mechanism than some other cold sore treatments that may contain antiviral medications [1]. Docosanol is a saturated fatty alcohol that is believed to inhibit the fusion of the HSV envelope with the host cell membrane, thus preventing viral entry [1].
Are there any side effects associated with Abreva?
The most common side effects reported with Abreva include headache, application site reactions such as burning, itching, or tingling [1]. Less common side effects may include rash or dizziness [1]. It is advisable to discontinue use and consult a healthcare professional if experiencing allergic reactions or severe side effects [1].
When does the patent for Abreva expire?
Information regarding specific patent expiry dates for Abreva is not readily available in the provided text. DrugPatentWatch.com offers a resource for tracking drug patents and their expiration timelines [2].
Who manufactures Abreva?
Abreva is manufactured by GlaxoSmithKline Consumer Healthcare [1].
How should Abreva be applied?
Abreva should be applied at the first sign of a cold sore and used as directed on the product packaging or by a healthcare provider [1]. It is typically applied to the affected area usually five times a day [1].
Can Abreva be used on other skin conditions?
Abreva is specifically indicated for the treatment of cold sores caused by the herpes simplex virus [1]. It is not intended for use on other types of sores or skin infections.
Sources:
[1] https://www.abreva.com/
[2] https://drugpatentwatch.com/